HCC gynecologic cancer research program completes successful audit
[June 22 2011] -
The Hospital of Central Connecticut’s Oncology Clinical Research program recently completed a successful audit by the Gynecologic Oncology Group (GOG), a national organization that works to promote excellence in gynecologic cancer clinical research.
As part of the triennial audit, GOG auditors scrutinized various aspects of the hospital’s gynecologic research program, including regulatory and pharmaceutical components and patient cases. Auditors complimented the program, which is headed by Gynecologic Oncologist James Hoffman, M.D.
“The audit team commended Dr. Hoffman and his staff for their high level of commitment and performance,” auditors wrote in their final report.
“This successful audit reflects the dedication of our physicians and staff to finding new ways to treat women’s cancers,” Hoffman said.
Hoffman praised The Hospital of Central Connecticut’s (HCC’s) clinical research staff, including Maureen Bracco, APRN, and clinical research associates Siobhan Reilly, Colby O’Rourke and the recently retired Cathy O’Dell. He also thanked Joel Sorosky, M.D., the hospital’s chief of obstetrics and gynecology, for his support of the gynecologic research program.
HCC serves as a GOG parent institution overseeing four affiliate institutions: Baystate Health Center, Springfield, Mass.; Hartford Hospital; Sinai Medical Center, Baltimore, Md.; and UConn Health Center.
Gynecologic clinical research is just one part of the hospital’s Oncology Clinical Research Program, which is also involved in other National Cancer Institute-sponsored studies for different types of cancer. Visit www.thocc.org/clinical to learn more.